Why the study?
Does platelet function monitoring with PFA-100 predict restenosis or reocclusion in PAOD patients undergoing PTA?
Population
98 patients with peripheral arterial occlusive disease undergoing elective percutaneous transluminal…
Comparison
Monitoring platelet function with the PFA-100… vs Responders to antiplatelet therapy.
Design
Cohort
Follow-up
12 months
Authors
Loading...
PFA-100 non-response was associated with higher restenosis risk after PTA; hypothesis-generating and should not yet change practice.
Does platelet function monitoring with PFA-100 predict restenosis or reocclusion in PAOD patients undergoing PTA?
Monitoring platelet function with PFA-100 may help identify patients on clopidogrel at elevated risk for restenosis or reocclusion after peripheral angioplasty.
Ziegler et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: